Panobinostat
規格
404950-80-7CAS番号
803-814-1EC番号
(E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamideIUPAC名
C21H23N3O2化学式
349.4 g/mol分子量
Panobinostat; 404950-80-7; LBH-589; Faridak; LBH 589; NVP-LBH589; 9647FM7Y3Z; (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide; (E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide; CHEBI:85990; DTXSID40193506; 2-Propenamide, N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)-, (2E)-; 2-Propenamide, N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino) methyl)phenyl)-, (2E)-; 2-Propenamide, N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-; Panobinostatum; (E)-N-hydroxy-3-(4-((2-(2-methyl-1H-indol-3-yl)ethylamino)methyl)phenyl)prop-2-enamide; (2E)-N-HYDROXY-3-(4-(((2-(2-METHYL-1H-INDOL-3-YL)ETHYL)AMINO)METHYL)PHENYL)PROP-2-ENAMIDE; RefChem:56999; NVP LBH589; DTXCID10115997; L01XX42; Farydak; Panobinostat (LBH589); (E)-N-Hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylamide; NVP-LBH-589; LBH-589B; Panobinostat(LBH589); (2E)-N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide; MFCD09833242; (E)-N-HYDROXY-3-(4-{[2-(2-METHYL-1H-INDOL-3-YL)-ETHYLAMINO]-METHYL}-PHENYL)-ACRYLAMIDE; Farydak (TN); Panobinostat(LBH-589); (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide; (E)-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enehydroxamic acid; (E)-N-hydroxy-3-(4-((2-(2-methyl-1H-indol-3-yl)ethylamino)methyl)phenyl)acrylamide; Panobinostat [INN]; Panobinostat [USAN:INN]; UNII-9647FM7Y3Z; 2-Propenamide, N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-; (2E)-N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide; Farydak; LBH 589; Panobinostat; 404950-80-7 (free base); Panobinostat, 98%; Panobinostat & Mukungulu; PANOBINOSTAT [MI]; Panobinostat (USAN/INN); PANOBINOSTAT [USAN]; Panobinostat (LBH-589); PANOBINOSTAT [MART.]; MLS006011216; NVP-LBH 589; PANOBINOSTAT [WHO-DD]; SCHEMBL164801; CHEMBL483254; GTPL7489; orb1225107; orb1305563; SCHEMBL22773814; BDBM29589; CHEBI:93774; EX-A169; FPOHNWQLNRZRFC-ZHACJKMWSA-N; N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]-2-propenamide; BDBM198124; GLXC-90040; HMS5079K05; LBH58,9NVP-LBH589,Panobinostat; (LBH-589); EBC-11340; NSC761190; AKOS005146046; CCG-208762; CS-0267; DB06603; EX-8456; FH26749; NSC-761190; NCGC00263117-05; NCGC00263117-07; NCGC00263117-10; NCGC00263117-17; AC-28652; AS-17046; HY-10224; SMR004702978; DB-025426; L0528; NS00071656; SW219369-1; D10319; EN300-7395075; F091845; Q7131441; BRD-K02130563-001-07-2; BRD-K02130563-001-11-4; BRD-K02130563-001-12-2; BRD-K02130563-001-14-8; N-hydroxy-3 -[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide; N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide別名
